InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (8 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by CRYSTAL ROGER, Chief Executive Officer. Officer active across 3 companies, notably Opiant Pharmaceuticals, INC.. Aggregated, 17 filings have been recorded. Breakdown: 2 buys · 8 sells. Total volume traded: €322k. History available since 16 September 2021. The latest transaction was filed on 21 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations17 total
4,666 sharesCommon SharesSEC:0001193125-26-271164:0
13,671 shares0Common SharesSEC:0000899243-23-016423:0
37,438 shares@ US$20.0068.6% of flowCommon StockSEC:0001385508-23-000069:0
1,358 shares@ US$20.262.5% of flowCommon StockSEC:0001385508-23-000034:0
1,183 shares@ US$20.202.2% of flowCommon StockSEC:0001385508-23-000018:0
5,029 shares@ US$20.209.4% of flowCommon StockSEC:0001385508-23-000005:0
89,286 shares0Common SharesSEC:0000899243-22-028728:0
2,246 shares@ US$11.112.4% of flowCommon StockSEC:0001385508-22-000109:0
6,667 shares0Common StockSEC:0001385508-22-000103:0
1,995 shares@ US$26.1530.2% of flowCommon StockSEC:0001385508-22-000025:0
1,995 shares@ US$26.154.5% of flowCommon StockSEC:0001385508-22-000025
1,058 shares@ US$30.492.8% of flowCommon StockSEC:0001385508-22-000020
1,058 shares@ US$30.4918.5% of flowCommon StockSEC:0001385508-22-000020:0
40,000 shares0Common StockSEC:0001385508-22-000008
40,000 shares0Common StockSEC:0001385508-22-000008:0
100 shares@ US$23.440.2% of flowCommon Stock par value $0.001SEC:0001385508-21-000134
Ideal exit: 13 Jun 2022 (T+270)
100 shares@ US$23.441.3% of flowCommon Stock par value $0.001SEC:0001385508-21-000134:0
Ideal exit: 13 Jun 2022 (T+270)
17 of 17 declarations
About CRYSTAL ROGER
Roger Crystal serves as Chief Executive Officer of Opiant Pharmaceuticals, Inc. In this role, he oversees the company's overall operations and defines its growth strategy. Roger brings extensive experience in the pharmaceutical sector, contributing to the direction and governance of Opiant. His commitment to innovation and operational efficiency is essential for the company's success.
